Caseware UK (AP4) 2023.0.135 2023.0.135 falseNo description of principal activitytrue22023-01-01true2 04201938 2023-01-01 2023-12-31 04201938 2022-01-01 2022-12-31 04201938 2023-12-31 04201938 2022-12-31 04201938 c:Director5 2023-01-01 2023-12-31 04201938 d:CurrentFinancialInstruments 2023-12-31 04201938 d:CurrentFinancialInstruments 2022-12-31 04201938 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 04201938 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 04201938 d:ShareCapital 2023-12-31 04201938 d:ShareCapital 2022-12-31 04201938 d:OtherMiscellaneousReserve 2023-12-31 04201938 d:OtherMiscellaneousReserve 2022-12-31 04201938 d:RetainedEarningsAccumulatedLosses 2023-12-31 04201938 d:RetainedEarningsAccumulatedLosses 2022-12-31 04201938 c:FRS102 2023-01-01 2023-12-31 04201938 c:Audited 2023-01-01 2023-12-31 04201938 c:FullAccounts 2023-01-01 2023-12-31 04201938 c:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 04201938 c:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure


















BRE-BMR CITP (Cambridge) Limited
























Financial statements



For the year ended 31 December 2023



Registered number: 04201938

 
BRE-BMR CITP (Cambridge) Limited - Registered number: 04201938

Statement of Financial Position
As at 31 December 2023

2023
2022
Note
£
£

  

Current assets
  

Debtors
 4 
123,328,097
123,325,853

Bank and cash balances
  
7,765
1,956

  
123,335,862
123,327,809

Creditors: amounts falling due within one year
 5 
(42,366,962)
(42,335,953)

Net current assets
  
 
 
80,968,900
 
 
80,991,856

Total assets less current liabilities
  
80,968,900
80,991,856

  

Net assets
  
80,968,900
80,991,856


Capital and reserves
  

Called up share capital 
  
1
1

Capital contributions
 6 
1,082,824
1,082,824

Profit and loss account
 6 
79,886,075
79,909,031

  
80,968,900
80,991,856


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Orestis Tzortzoglou
Director

Date: 24 September 2024

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
BRE-BMR CITP (Cambridge) Limited

 
Notes to the Financial Statements
For the year ended 31 December 2023

1.


General information

BRE-BMR CITP (Cambridge) Limited is a private company limited by shares and is incorporated in England and Wales. The registered office of the company is C/O Buzzacott LLP, 130 Wood Street, London, EC2V 6DL and the principal place of business is The McClintock Building, Granta Park, Great Abington, Cambridge, CB21 6GP. The registered number is 04201938.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland' ('FRS 102') and the Companies Act 2006.

 
2.2

Going concern

The directors have received assurance from BRE-BMR CITP Holdco Limited that it will provide continuing financial support to the company sufficient to allow it to continue trading for the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.
However, should this support be withdrawn or future funding not be available, the going concern basis used
in preparing the company's financial statements may be invalid and adjustments would have to be made to
reduce the value of the assets to their realisable amount and to provide for any further liabilities that might
arise. The financial statements do not include any adjustment to the company's assets or liabilities that might
be necessary should the going concern basis not continue to be appropriate.

 
2.3

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates income.

Page 2

 
BRE-BMR CITP (Cambridge) Limited

Notes to the Financial Statements
For the year ended 31 December 2023

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. 

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2022 - 2).


4.


Debtors

2023
2022
£
£


Amounts owed by group undertakings
122,372,053
122,359,692

Other debtors
956,044
966,161

123,328,097
123,325,853



5.


Creditors: Amounts falling due within one year

2023
2022
£
£

Amounts owed to group undertakings
42,197,793
42,149,240

Accruals and deferred income
169,169
186,713

42,366,962
42,335,953



6.


Reserves

Profit and loss account - includes all current and prior period retained profit and losses.
Capital contribution reserve - includes amounts contributed to the company by the parent company.


7.


Inclusion in consolidated financial statements

BioMed Realty, L.P. is the parent company of the smallest group of which the company is a member
and for which group financial statements are prepared. The registered office of BioMed Realty, L.P. is
7 St. Paul Street, Suite 820, Baltimore MD, 21202, United States.

Page 3

 
BRE-BMR CITP (Cambridge) Limited

 
Notes to the Financial Statements
For the year ended 31 December 2023

8.


Auditor's information

The auditor's report on the financial statements for the year ended 31 December 2023 was unqualified.

The audit report was signed on 25 September 2024 by Mark Worsey (Senior Statutory Auditor) on behalf of Buzzacott LLP.

Page 4